| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/07/2005 | US20050075383 Inhibitors of phophodiesterase type-IV |
| 04/07/2005 | US20050075382 Compounds as bactericides or drugs |
| 04/07/2005 | US20050075381 a [4-(5-phenyl)oxazolyl]-N-acetyl pyrrolidine or a [1-amino-2-hydroxy-2-phenylethyl]-N-acetyl pyrrolidine; enzyme inhibitors; anticarcinogenic, antitumor agents |
| 04/07/2005 | US20050075379 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075372 Method for controlling particular insect pest by applying anthranilamide compounds |
| 04/07/2005 | US20050075364 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage |
| 04/07/2005 | US20050075346 Novel compounds |
| 04/07/2005 | US20050075345 1,2,4-Oxadiazoline-5-one or thiazolidine-2,4-dione derivatives; hypertensive, antiinflammatory, antiallergen, antiischemic, antihistamine, bronchodilator, and anticarcinogenic agents; cardiovascular, skin, gastrointestinal, and respiratory system disorders; cyclization, catalytic hydrogenation |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 04/07/2005 | US20050075333 Substituted quinazolines and pyrimidinopyridines useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes; compounds modulate the expression and/or function of a chemokine receptor |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/07/2005 | DE10342292A1 New macrolide oxazolidinone derivatives useful for treating bacterial infections |
| 04/07/2005 | CA2744997A1 C-met modulators and method of use |
| 04/07/2005 | CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | CA2540019A1 Quinazoline derivatives as antiproliferative agents |
| 04/07/2005 | CA2540008A1 Quinazoline derivatives |
| 04/07/2005 | CA2538671A1 Substituted oxadiazolidinediones als pai-1 inhibitors |
| 04/07/2005 | CA2538353A1 Substituted oxadiazolidinediones as pai-1 inhibitors |
| 04/07/2005 | CA2537877A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 04/07/2005 | CA2537812A1 C-met modulators and method of use |
| 04/07/2005 | CA2537004A1 Therapeutic agents useful for treating pain |
| 04/06/2005 | EP1519924A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 04/06/2005 | EP1519921A2 Substituted anthranilic amide derivatives and methods of use |
| 04/06/2005 | EP1519722A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | EP1202975B1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 04/06/2005 | EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195753C Fused-benzene derivatives useful as herbicides |
| 04/06/2005 | CN1195751C Thiophen sulfuryl compound |
| 04/06/2005 | CN1195749C Method for the preparation of 5-cyanophthalide |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 04/05/2005 | US6875871 Oxazolidinone photoaffinity probes |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875859 Heterocyclic compounds and their use in the detection of nucleic acids |
| 04/05/2005 | US6875784 Bactericides; grampositive, gramnegative bacteria |
| 04/05/2005 | US6875782 Antidiabetic agents, dietetics, anticancer agents |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875776 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 04/05/2005 | US6875770 Antiinflamamtory agents; side effect reduction |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875761 Certain 1,3-disubstituted isoquinoline derivatives |
| 04/05/2005 | CA2339621C 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 04/05/2005 | CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 03/31/2005 | WO2005028475A2 Compositions useful as inhibitors of protein kinases |
| 03/31/2005 | WO2005028473A1 Acyloxymethylcarbamate prodrugs of oxazolidinones |
| 03/31/2005 | WO2005028465A1 Chromene compound |
| 03/31/2005 | WO2005028453A1 Phenylacetic acid derivative, process for producing the same, and use |
| 03/31/2005 | WO2005028444A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/31/2005 | WO2005028443A2 Protein tyrosine kinase enzyme inhibitors |
| 03/31/2005 | WO2005028440A1 Novel gamma secretase inhibitors |
| 03/31/2005 | WO2005028436A2 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | WO2005027823A2 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 03/31/2005 | WO2005027637A1 Compounds useful as motilin agonists and method |
| 03/31/2005 | WO2005000841A8 Preparation of n2-alkylated 1,2,3-triazoles |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | WO2004108086A3 HYDANTOIN DERIVATIVES AS INHIBITORS OF TUMOR NECROSIS FACTOR-α CONVERTING ENZYME (TACE) |
| 03/31/2005 | WO2004103973A8 Phenyl quinolines and their use as estrogen receptor modulators |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | WO2004094449A8 Macrolide-conjugates with anti-inflammatory activity |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/31/2005 | US20050070721 PH-sensitive polymeric micelles for drug delivery |
| 03/31/2005 | US20050070718 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/31/2005 | US20050070714 Process for the production of chiral propionic acid derivatives |
| 03/31/2005 | US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease |
| 03/31/2005 | US20050070589 Pyrazolyl inhibitors of 15- lipoxygenase |
| 03/31/2005 | US20050070585 Serine protease inhibitor; angiogenesis factor; antitumor agents; atherosclerosis; thrombosis; chronic obstructive pulmonary disorders; Alzheimer's disease; anticancer agents; antidiabetic agents; cardiovascular disorders |
| 03/31/2005 | US20050070580 N-{3-[3-fluoro-4-(4-oxo-3,4-dihydro-2H-pyridin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide; treating gram-negative organisms such as Haemophilus influenza and Moraxella catarrhalis. |
| 03/31/2005 | US20050070573 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 03/31/2005 | US20050070562 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/31/2005 | US20050070545 For treatment or prevention of metabolic and cell proliferative diseases; modifying lipid metabolism |
| 03/31/2005 | US20050070538 Compounds and uses thereof in modulating amyloid beta |
| 03/31/2005 | US20050070534 Non-peptidic NPY Y2 receptor inhibitors |
| 03/31/2005 | US20050070526 Novel antibacterial agents |
| 03/31/2005 | US20050070523 For therapy of bacterial infection in a mammal |
| 03/31/2005 | US20050070520 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | US20050067955 Prepared, for example, by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices |
| 03/31/2005 | CA2808646A1 Thalidomide analogs |
| 03/31/2005 | CA2539848A1 Acyloxymethylcarbamate prodrugs of oxazolidinones |
| 03/31/2005 | CA2539554A1 Phenylacetic acid derivative, process for producing the same, and use |
| 03/31/2005 | CA2539162A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | CA2538864A1 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | CA2538855A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/31/2005 | CA2538590A1 Novel gamma secretase inhibitors |
| 03/31/2005 | CA2538381A1 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 03/31/2005 | CA2537731A1 Compositions useful as inhibitors of protein kinases |
| 03/30/2005 | EP1518855A1 Diaminopyrimidinecarboxa mide derivative |
| 03/30/2005 | EP1517974A1 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 03/30/2005 | EP1517899A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |